Slow release formulation of clarithromycin

Details Slow release formulation of clarithromycin Slow release formulation of clarithromycin

A - Human Necessities

61

K

A61K 9/22 (2006.01) A61K 9/20 (2006.01) A61K 31/7048 (2006.01) A61K 9/28 (2006.01)

Patent

CA 2505599

The invention relates to an orally administrable pharmaceutical composition comprising an alginate matrix consisting of a water-soluble alginate salt and a complex salt of alginic acid, a macrolide, and an inorganic salt characterized in that the inorganic salt is capable of donating a proton and has a pKa value in water of 4.0 to 9Ø

L'invention concerne une composition pharmaceutique administrable par voie orale, comprenant une matrice d'alginate constituée d'un sel alginate hydrosoluble et d'un sel complexe d'acide alginique, d'un macrolide et d'un sel inorganique caractérisé en ce qu'il est capable de donner un proton et qu'il présente une valeur pK¿a? dans l'eau comprise entre 4,0 et 9,0.

Affiliated with

Also associated with

Rating

Slow release formulation of clarithromycin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Slow release formulation of clarithromycin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Slow release formulation of clarithromycin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1936785